X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4796) 4796
Book Review (648) 648
Publication (387) 387
Newsletter (83) 83
Conference Proceeding (35) 35
Book Chapter (9) 9
Magazine Article (9) 9
Dissertation (5) 5
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3816) 3816
humans (3343) 3343
clarithromycin (3034) 3034
helicobacter pylori (1836) 1836
male (1771) 1771
female (1748) 1748
helicobacter infections - drug therapy (1548) 1548
anti-bacterial agents - therapeutic use (1388) 1388
helicobacter pylori - drug effects (1337) 1337
middle aged (1332) 1332
microbiology (1327) 1327
infection (1312) 1312
adult (1283) 1283
anti-bacterial agents - pharmacology (1242) 1242
gastroenterology & hepatology (1184) 1184
clarithromycin - therapeutic use (1150) 1150
pharmacology & pharmacy (1074) 1074
clarithromycin - pharmacology (1057) 1057
microbial sensitivity tests (1043) 1043
drug therapy, combination (1038) 1038
aged (959) 959
amoxicillin (910) 910
treatment outcome (854) 854
metronidazole (818) 818
resistance (799) 799
eradication (797) 797
infectious diseases (773) 773
helicobacter infections - microbiology (765) 765
antibiotics (739) 739
drug resistance, bacterial (714) 714
anti-bacterial agents - administration & dosage (631) 631
clarithromycin - administration & dosage (611) 611
triple therapy (601) 601
antibiotic-resistance (589) 589
amoxicillin - therapeutic use (547) 547
helicobacter pylori - isolation & purification (547) 547
therapy (517) 517
adolescent (513) 513
prevalence (459) 459
drug resistance, microbial (456) 456
infections (456) 456
clarithromycin resistance (454) 454
helicobacter pylori - genetics (448) 448
omeprazole (446) 446
azithromycin (424) 424
helicobacter infections (407) 407
drug resistance (404) 404
management (398) 398
levofloxacin (392) 392
antimicrobial resistance (390) 390
efficacy (381) 381
amoxicillin - administration & dosage (380) 380
susceptibility (378) 378
health aspects (373) 373
prospective studies (373) 373
drug resistance in microorganisms (356) 356
metronidazole - therapeutic use (348) 348
child (346) 346
animals (339) 339
aged, 80 and over (328) 328
anti-ulcer agents - therapeutic use (328) 328
abridged index medicus (324) 324
drug administration schedule (313) 313
anti-bacterial agents - adverse effects (312) 312
antibiotic resistance (306) 306
erythromycin (304) 304
medicine, general & internal (303) 303
metronidazole - pharmacology (303) 303
children (299) 299
strains (290) 290
care and treatment (289) 289
drug therapy (289) 289
metaanalysis (285) 285
research (278) 278
macrolides (276) 276
young adult (276) 276
omeprazole - therapeutic use (271) 271
helicobacter infections - diagnosis (266) 266
analysis (265) 265
proton pump inhibitors (265) 265
mutation (259) 259
bacteria (256) 256
biopsy (256) 256
lansoprazole (251) 251
bacterial infections and mycoses (248) 248
helicobacter infections - epidemiology (240) 240
polymerase chain reaction (240) 240
amoxicillin - pharmacology (237) 237
antimicrobial agents (233) 233
proton pump inhibitors - therapeutic use (230) 230
clarithromycin - adverse effects (226) 226
metronidazole - administration & dosage (226) 226
drug resistance, bacterial - genetics (224) 224
metronidazole resistance (224) 224
in-vitro (222) 222
child, preschool (220) 220
treatment failure (218) 218
duodenal-ulcer (216) 216
rna, ribosomal, 23s - genetics (216) 216
immunology (215) 215
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4518) 4518
Japanese (105) 105
Spanish (82) 82
French (50) 50
Korean (37) 37
German (31) 31
Chinese (30) 30
Turkish (13) 13
Polish (10) 10
Russian (9) 9
Hungarian (8) 8
Portuguese (7) 7
Czech (4) 4
Dutch (4) 4
Italian (3) 3
Hebrew (2) 2
Swedish (2) 2
Danish (1) 1
Norwegian (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 01/2013, Volume 62, Issue 1, pp. 34 - 42
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 3, pp. e9836 - e9836
Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer.... 
CLARITHROMYCIN | RESISTANCE GENES | INTESTINAL MICROFLORA | HELICOBACTER-PYLORI INFECTION | FLORA | PERSISTENCE | BIOLOGY | POPULATIONS | MACROLIDE RESISTANCE | GRADIENT GEL-ELECTROPHORESIS | 16S RIBOSOMAL-RNA | Oligonucleotides - genetics | Dyspepsia - drug therapy | Humans | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Drug Resistance, Microbial - genetics | Phylogeny | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Polymorphism, Restriction Fragment Length | Time Factors | Clarithromycin - administration & dosage | RNA, Ribosomal, 16S - genetics | Feces | Pharynx - drug effects | Pharynx - microbiology | Drug resistance in microorganisms | Care and treatment | Antibiotics | Microbiota (Symbiotic organisms) | RNA | Analysis | Peptic ulcer | Stomach cancer | Antiulcer drugs | Short term | Microbial activity | Clarithromycin | rRNA 16S | Microbiology | Genes | Colorectal cancer | Biology | Drug resistance | Gene polymorphism | Data bases | Microorganisms | Helicobacter pylori | Intestine | Antibiotic resistance | Phylogenetics | Bacteria | Gastric cancer | Deoxyribonucleic acid--DNA | Pharynx | Disease control | Bacteriology | Polymerase chain reaction | Infectious diseases | Restriction fragment length polymorphism | Metronidazole | Cancer | Long-term effects | Polymorphism | Index Medicus | ULCERS | ANTIBIOTICS | DISEASES | THERAPY | NEOPLASMS | GENES | FECES | COMMUNITIES | METRONIDAZOLE | Microbial/genetics | Ribosomal | Pharynx/drug effects/microbiology | Restriction Fragment Length | Gastrointestinal Tract/drug effects/microbiology | Clarithromycin/administration & dosage | Omeprazole/administration & dosage | Metronidazole/administration & dosage | Oligonucleotides/genetics | Naturvetenskap | Natural Sciences | Dyspepsia/drug therapy | 16S/genetics | Anti-Bacterial Agents/therapeutic use | Drug Resistance | Deoxyribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, pp. e0124199 - e0124199
Objective The Taiwan Government issued a policy to restrict antimicrobial usage since 2001. We aimed to assess the changes in the antibiotic consumption and... 
TRIAL | MULTICENTER | EVOLUTION | EFFICACY | MULTIDISCIPLINARY SCIENCES | TRIPLE THERAPIES | ERADICATION THERAPY | INFECTION | PREVALENCE | 1ST-LINE | ANTIMICROBIAL RESISTANCE | Helicobacter pylori - growth & development | Humans | Tetracycline - pharmacology | Helicobacter pylori - genetics | Tetracycline - therapeutic use | Genotype | Helicobacter pylori - drug effects | Male | Clarithromycin - therapeutic use | Virulence Factors | Metronidazole - pharmacology | Anti-Bacterial Agents - therapeutic use | Amoxicillin - pharmacology | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | Taiwan | Female | Anti-Bacterial Agents - pharmacology | Clarithromycin - pharmacology | Drug resistance in microorganisms | Complications and side effects | Demographic aspects | Patient outcomes | Amoxicillin | Helicobacter infections | Dosage and administration | Genetic aspects | Research | Drug therapy | Fluoroquinolones | Levofloxacin | Clarithromycin | Insurance claims | Physicians | Virulence | Infections | Males | Drug resistance | Antiinfectives and antibacterials | Consortia | Helicobacter pylori | Virulence factors | Antibiotic resistance | Gastroenterology | Consumption | Health insurance | Departments | Internal medicine | Agar | Sex differences | Antimicrobial agents | Agar dilution test | Resistance factors | Nitroimidazole | Medicine | Dilution | Hospitals | Antibiotics | Genotyping | Gastrointestinal diseases | Ulcers | Minimum inhibitory concentration | Metronidazole | Females | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2005, Volume 102, Issue 14, pp. 5180 - 5185
Journal Article
Journal Article
Journal of Gastrointestinal and Liver Diseases, ISSN 1841-8724, 12/2010, Volume 19, Issue 4, pp. 409 - 414
Background and Aims. Prevalence of H. pylori antibiotic resistance is increasing worldwide, and it is the main factor affecting efficacy of current therapeutic... 
Resistance | Antibiotic | Worldwide | Helicobacter pylori | antibiotic | STRAINS | RISK-FACTORS | CLARITHROMYCIN RESISTANCE | PREVALENCE | ANTIMICROBIAL RESISTANCE | resistance | THERAPY | LEVOFLOXACIN | worldwide | ERADICATION | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | HELICOBACTER-PYLORI
Journal Article
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 07/2018, Volume 48, Issue 1, pp. 95 - 96
Linked Content This article is linked to Gatta et al and Gatta and Scarpignato papers. To view these articles visit https://doi.org/10.1111/apt.14597 and... 
GASTROENTEROLOGY & HEPATOLOGY | PHARMACOLOGY & PHARMACY | Drug Resistance, Microbial | Clarithromycin | Helicobacter Infections | Helicobacter pylori | Humans
Journal Article
Helicobacter, ISSN 1083-4389, 12/2017, Volume 22, Issue 6, pp. e12447 - n/a
Journal Article